Share on StockTwits

Coronado Biosciences (NASDAQ:CNDO) announced its earnings results on Tuesday. The company reported ($0.13) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.17) by $0.04, ARN reports.

Coronado Biosciences (NASDAQ:CNDO) opened at 1.50 on Tuesday. Coronado Biosciences has a 52-week low of $1.25 and a 52-week high of $9.58. The stock has a 50-day moving average of $1.63 and a 200-day moving average of $1.98. The company’s market cap is $66.5 million.

Coronado Biosciences, Inc is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.

Receive News & Ratings for Coronado Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coronado Biosciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.